Stock Ratings / Health Care / ICU / options

SINT (37) FEMY (35) GUTS (52) CNSY (36) ⌘ Pro Terminal →

SeaStar Medical Holding Corporation (ICU) Options Positioning, Max Pain & Unusual Sweeps

$2.31 -6.85% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)

SeaStar Medical Holding Corporation (ICU) carries a Roarable Rating of E (Strong Sell) with 33/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE E • RED ALERT Cap $12.2M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERRED ALERT • E

2-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE-11.3% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for ICU)Realized 20D OHLCV Swing Band: ±12.5%

CALL VS. PUT WHALE SHARE

— (No Active Options Snapshot)

Put/Call Ratio: — (No Active Options Snapshot)

MAX-PAIN EXPIRATION MAGNET

— (No Active Options Snapshot)

No active options chain max-pain snapshot on file

HISTORICAL 20D VOLATILITY SWING

±12.5%

Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (ICU)

— (No Active Options Snapshot) — No unusual CBOE strike concentration anomalies recorded in the current database snapshot for ICU.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

🏆 Enter Free $100K Paper Arena →

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring ICU)

✓Walkthrough of ICU's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

ICU // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -44.20%▼ SUPPORT BREAKDOWN

2026-10-30O $2.30H $2.31L $2.14C $2.31VOL 81.2K

RES: $5.31SUP: $2.74SMA50: $3.20SMA200: $3.33

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

ICU Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 ICU Butterfly Map → + Track ICU →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +180.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on ICU today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for ICU. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for ICU today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ICU)

Health Care Rank #880 of 1016 ⚔️ SINT vs ICU Full Matrix →

1. Head-to-Head Health Care Peer Comparison (ICU vs. SINT, FEMY, GUTS, CNSY)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, SeaStar Medical Holding Corporation (ICU) ranks #880 by composite RQD confidence (33/100, grade E) and #878 by equity capitalization ($12.2M). Within this direct 5-issuer industry benchmark cohort, ICU leads on earnings valuation at N/A trailing P/E, while ICU leads on capital efficiency and profitability with -35.0% ROIC and 95.7% gross margin. GUTS currently holds the highest overall quantitative score in the immediate peer group at 52/100 (D+) compared with ICU at 33/100 (E).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
ICU ACTIVE SeaStar Medical Holding Corporation	E	33/100	—	95.7%	-35.0%	-6.85%	$12.2M	Benchmark Subject
SINT SiNtx Technologies Inc.	D-	37/100	—	45.3%	-35.0%	-1.15%	$13.0M	/sint-vs-icu →
FEMY Femasys Inc.	D-	35/100	—	62.0%	-35.0%	-3.90%	$11.3M	/femy-vs-icu →
GUTS Fractyl Health Inc.	D+	52/100	—	—	-35.0%	+11.40%	$13.2M	/guts-vs-icu →
CNSY Cerenome Inc.	D-	36/100	—	—	-35.0%	0.00%	$13.2M	/cnsy-vs-icu →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001831868

In its most recent audited fiscal period (FY2025, filed 2025-12-31), SeaStar Medical Holding Corporation (ICU) reported GAAP revenue of $1.2M (+814.1% vs. FY2024 revenue of $135.0K ) , GAAP net income of -$12.2M, operating cash flow of -$13.6M, and free cash flow of -$13.6M (+15.0% YoY). On the balance sheet, ICU closed FY2025 with $14.2M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 4/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$1.2M	-$12.2M	-$13.6M	-$13.6M	$14.2M	—
FY2024 (FY)	2024-12-31	$135.0K	-$24.8M	-$16.0M	-$16.0M	$4.7M	—
FY2023 (FY)	2023-12-31	$0	-$26.2M	-$10.3M	-$10.3M	—	—

3. ICU Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is ICU stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, SeaStar Medical Holding Corporation (NASDAQ: ICU) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 33/100 at a spot price of $2.31 (-6.85% 1D, market cap $12.2M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 5/20, Executive Insider Alignment 11/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 5/20. Across 1016 tracked Health Care issuers, ICU ranks #880 in composite RQD confidence.

How does ICU compare to SINT and FEMY in the Health Care sector?

Within the Health Care sector (Medical/Dental Instruments), ICU carries a Roarable E (33/100 RQD), trailing P/E of N/A, gross margin of 95.7%, and ROIC of -35.0%. By comparison, SINT (SiNtx Technologies Inc.) holds a D- grade (37/100 RQD, P/E N/A, ROIC -35.0%, cap $13.0M) and FEMY (Femasys Inc.) posts a D- grade (35/100 RQD, P/E N/A, ROIC -35.0%, cap $11.3M). Among the 5-stock peer group, ICU leads on earnings multiple (N/A) while ICU leads on capital efficiency (-35.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for ICU?

Per ICU's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001831868), SeaStar Medical Holding Corporation generated $1.2M in revenue (+814.1% YoY), -$12.2M in net income, and -$13.6M in free cash flow against $14.2M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is ICU trading relative to its 50-day, 200-day, and 52-week technical levels?

ICU last traded at $2.31 (-6.85% on volume of 124,439 shares), positioning the stock -27.81% below its 50-day simple moving average ($3.20) and -30.63% below its 200-day simple moving average ($3.33). Across its 52-week range of $2.07 to $6.00, ICU sits at the 6.1% percentile with a 14-day RSI of 35.4 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($2.02 to $2.60).

ICU Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is ICU's options positioning and volatility profile?

Roarable tracks verified CBOE unusual options sweeps, put/call ratios, and OHLCV realized volatility bands for ICU.

Direct Sub-Reports: ICU RQD Cockpit ICU 12M Forecast ICU Earnings & Move ICU Dividends & DRIP ICU Insiders & 13F ICU Whale Options ICU Profit Sankey ICU News & Why